Shang-Jyh Hwang, M.D. Division of Nephrology, Dept. of Medicine - - PowerPoint PPT Presentation

shang jyh hwang m d
SMART_READER_LITE
LIVE PREVIEW

Shang-Jyh Hwang, M.D. Division of Nephrology, Dept. of Medicine - - PowerPoint PPT Presentation

2017 QS QS Subject Focus Summit on Medicine Universities Innovating for Future Healthcare October 17, 2017; KMU International Convention Center Measuring Quality of Care in Patient-centered Integrated Care


slide-1
SLIDE 1

Shang-Jyh Hwang, M.D. 黃尚志

Division of Nephrology, Dept. of Medicine Kaohsiung Medical University & Hospital, Taiwan Taiwan Society of Nephrology Measuring Quality of Care in Patient-centered Integrated Care – Chronic Kidney Disease Integrated Care in Taiwan

2017年QS醫學高峰會 創新醫療照護 QS Subject Focus Summit on Medicine Universities Innovating for Future Healthcare October 17, 2017; KMU International Convention Center

slide-2
SLIDE 2

William Edwards Deming (1900-1993)

What is Quality?

 Fit the

requirements & specifications

 Fit for using  User Satisfaction  Value at an

affordable price

Donabedian

model

Structure Process Outcome

Dimensions of Care

(Avedis Donabedian 1919~2000)

slide-3
SLIDE 3

Structure

Manpower Facility

Process

Examination Medication Procedure Operation

Outcome

Length of Stay Unplanned Return Infection Fall Mortality

Patient-centered of Quality ?

slide-4
SLIDE 4

Measure systems in Taiwan

 Taiwan Clinical Performance Indicator, TCPI  Hospital Performance & Improvement, P4P  Hospital Accreditation Monitor System , HA  Health Insurance Monitor System , HI

TCPI P4P HA HI Types

Structure

Process

√ √

Outcome

√ √ √ √

Data Source

Patient Records Patient Records Hospital Records Application Data

Quantity

(All/KMUH)

472(164) 58(58) 58(58)

Frequency

Monthly Monthly Annually Quarterly

Fee

Yes No No No

slide-5
SLIDE 5

Pneumonia Stroke AMI CKD DM

Quality of Care Measured at Patient Level

slide-6
SLIDE 6

CKD integrated care in Taiwan Outlines

I.

Brief on the Taiwan CKD prevention

II.

The 5-year CKD Prevention and Quality of Care Improvement Project

  • III. The New Cardiac-Kidney-Diabetes-Neuro Project
  • IV. Prospective
slide-7
SLIDE 7

7

USRD, 2014 annual report

Incidence of ESRD

USRD, 2014 annual report

Prevalence of ESRD

High ESRD incidence and high prevalence

  • f ESRD

in Taiwan

slide-8
SLIDE 8

CKD Prevention Project in Taiwan

 High incidence & high

prevalence of dialysis ESRD

 High prevalence of CKD  High medical costs for

ESRD and CKD We must do something to improve the condition.

 Structure & Policy

 Government, TSN, Medical

Facilities, Private organization, Publics  Process

 Kidney health promotion

program

 Pre-ESRD program  Early CKD program  Physical checkup for adults

and elderly

Why did we need?

How did we do?

slide-9
SLIDE 9

Projects from different institutes for CKD prevention in Taiwan, 2001-2011

2001, TSN collaborated with USRDS to publish ESRD data of Taiwan

2002, TSN urged to prevent kidney disease in the Committee of Prevention of Diseases of Middle Age, DOH Taiwan

2002-3, Pilot projects from Bureau of Health Promotion, DOH

2003, TSN organized the CKD Prevention Committee 

2003, Bureau of Health Promotion and TSN launched the Kidney Health Promotion Program

2005, Taiwan Kidney Day (TSN,BHP).

2006, World Kidney Day (ISN, IFKF) 

2007, Bureau of National Health Insurance launched the Pre- ESRD Integrated Care Program

2009, BHP launched the CKD Prevention Research Project 

2011, BNHI launched the Early CKD Care Program

slide-10
SLIDE 10

Projects and actions for CKD prevention in Taiwan, 2011-2016

 (2001 Diabetes integrated care

program)

 2011 Kidney Health Forum

(NHRI)

 2012 CKD Prevention and

Quality of Care Improvement 5-year Project (慢性腎臟病防治

與照護品質五年提升計畫 2012-2016) (Ministry of Health and Welfare)

 2014 First Annual Report on

Kidney Disease in Taiwan (NHRI)

 2015 CKD Practice Guideline

(NHRI)

 2016 Renal Injury Prevention

and Drug Safety

slide-11
SLIDE 11

Taiwan CKD prevention works from 2003 to 2016

slide-12
SLIDE 12

Summary on the CKD prevention Project

  • Set up a well-organized infrastructure
  • Deployed many projects for community screening,

education, and clinical care plan to cover all stages CKD patients

  • Established the patient-centered integrated care

program

  • A unique pay-for-performance reimbursement

system from National Health Insurance

  • Designed effective policies to drive the intention of

hospitals and clinicians to join the programs

  • Evaluating the performance in Early CKD and PreESRD

programs

slide-13
SLIDE 13 2003 2004 2005 2006 2007 2008 2009 2010 20 40 60 80 100 120 12 5 19 44

Year

83 78 89 108

No.

  • I. Kidney Health Promotion Project, Bureau of Health Promotion,

Department of Health CKD Prevention Clinics/Hospitals, 2003~

Fundamental and essential process for establishment of CKD prevention and care system nation-wide

slide-14
SLIDE 14

CKD natural course and treatment strategy

Complications

Normal High Risk

Injured GFR ↓

Renal Failure Death

CKD risk factors screening Screening & Reduce risk factors Dx, Tx, Eval. Retard progression

Evaluate speed of Progression Tx of complications Preparation for ESRD

Preparation and perform RRT

Levey AS et al, Kidney Int 2007

Retard progression Treat complications Prevent early death

slide-15
SLIDE 15

What is the effectiveness of the CKD prevention project? Measuring Quality of Care

 Final goal:

 Decrease ESRD incident rate in Taiwan

 Decrease the CKD cases number  Slow the CKD progression

 Goals at initial development stages:

 Promoting the concept and establishment of CKD prevention

  • rganizations

 Follow the preset goals of care at different CKD stages  Immediate effect of cost saving for Pre-ESRD care

 Care quality for CKD stage 5 entering ESRD - RRT  Medical utilization for CKD stage 5 entering ESRD - RRT

slide-16
SLIDE 16

 Kidney health promotion program  Pre-ESRD program 1)

Local hospitals

2)

National Dataset Analysis A (NHRI)

3)

National Dataset Analysis P4P program (KMUH)

 Early CKD program (KMU)  Adult Prevention Health Exam Service  2014 ~ 2016 ESRD annual data report  DM integrated care program  Taiwan CKD cohort

Effects and Accomplishments

Taiwan CKD Prevention Project

slide-17
SLIDE 17

Quality of CKD care in patients entering ESRD, 2005-2012

0% 10% 20% 30% 40% 50% 60% 70% 80% 90%

EPO Tx Hct>28% Albumin PD VA Prepared PD Cath. Prepared W/O Temp. Cath. OPD start dialysis 2005 2006 2007 2008 2009 2010 2011 2012

 Kidney health promotion program

slide-18
SLIDE 18

Summary on effectiveness of the Pre-ESRD program

(results from the before mentioned local studies)

 Multidisciplinary CKD care can  Reduce mortality for advanced CKD patients  Increase vascular access rate for dialysis  Decrease hospitalization during dialysis initiation  Reduce medical costs during dialysis initiation  Slow GFR declining rate for advanced CKD

patients

 Reduce dialysis rate?

 No - Changhua Christian Hospital  Yes – NTU, Chang Gung Memorial Hospital  Pre-ESRD program: 1) Local hospitals

Nephrology 2010;15:108-115 NDT 2009;24:3426-3433

  • Nephrology. 2014;19:699-707

NDT 2013.28:671-682 Am J Medicine. 2015;128:68-76

slide-19
SLIDE 19

Summary of the results of Early CKD and Pre- ESRD Program

 Early CKD Program (National Dataset

Analysis)

 Lower medical costs  Better survival  Good laboratory examination rate

 Pre-ESRD P4P program (National

Dataset Analysis)

 Improvement of clinical care quality  Better lab. data and less complications  Less mortality  Delay the time to dialysis  Well preparation at time of dialysis

initiation

 Low medical costs

 Pre-ESRD program: 3) National Dataset Analysis (KMUH)

Log-rank test Chi-square test=705.94 (p<0.001) 0.00 0.20 0.40 0.60 0.80 1.00 69788 50245 35256 24020 14048 6204 2 P4P 69788 48293 32843 21888 12565 5495 11 Non-P4P Number at risk 1 2 3 4 5 6 Follow-up Time (Years) Non-P4P P4P

P4P patients has lower cumulative crude morality rate, and the average days from enrollment to death is also longer than the controls.

Lower 1-5 years mortality after enrollment

slide-20
SLIDE 20

Increasing cover rates of different integrated care programs: DM, Early CKD, and Pre-ESRD program

20

23.2% 24.7% 26.3% 27.6% 29.3% 31.2% 33.9% 35.1% 38.5% 41.1% 15.1% 26.4% 29.4% 36.5% 38.5% 39% 51% 55% 58% 10% 30% 50% 95 96 97 98 99 100 101 102 103 104

Pre Pre-ESRD ESRD

DM DM

Early ly CKD

2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016, Tw RDS ADR

slide-21
SLIDE 21
  • II. 2012~2016 CKD Prevention and Quality of Care

Improvement 5-year Project : By Ministry of Health and Welfare Aim, Goal, Indicators Monitoring, Evaluation (2013-2016)

  • 1. Decrease dialysis Incidence Rate (Annual growth
  • f age- standardized dialysis incidence rate -2%)
  • 2. Increase the numbers of renal transplantation

(annual growth rate 3%)

  • 3. Improve dialysis 5-year survival rate (3% higher

than EDTA Registry)

  • 4. Increase peritoneal dialysis penetration rate

(annual growth rate 1% for age less than 55 years and non-diabetes group)

slide-22
SLIDE 22

2000~2016 Dialysis Incidence Rate in Taiwan

註: 1.透析標準需滿足門診透析連續3個月以上。 2.2016年數據乃推估而來,資料僅供參考。 3.年齡標準化發生率是以WHO 2000年的標準人口為準。 11 11 314 324 330 338 345 366 373 392 408 414 439 431 445 458 455 476 476 310 311 311 309 307 318 315 323 325 321 330 314 316 317 305 312 307

150 300 450 600 3 6 9 12 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

  • No. x 1000

發生數 粗發生率 年齡標準化發生率 Incidence (per million population)

Standardared incidence rate: 2007-2016)-0.5% 2012-2016)-0.5% 2014-2016)+0.2% Crude Incidence rate 2007-2016)+2.2% 2012-2016)+1.4% 2014-2016)+1.6%

Numbers Crude incidence rate Standardized incidence rate

Aim 1: Decrease the dialysis incidence rate 2016, Tw RDS ADR

slide-23
SLIDE 23

Age-specific Dialysis Incidence Rate

558 502 503 474 491 498 1,457 1,749 1,734 1,660 1,688 1,592 1,633 2,675 2,720 2,784 2,808 2,693

1,000 2,000 3,000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 <40 40-64 65-74 75+ p.m,p, 2012-2015: +1.7%/year 2012-2015: -1.2%/year

2012-2015: -0.7%/year

1. Decrease dialysis Incidence Rate (Annual growth of age- standardized dialysis incidence rate -2%)

Not achieved : 2016 vs. 2015, 2015 vs. 2014:-1.3%, +2.0%

Aim

2016, Tw RDS ADR

slide-24
SLIDE 24

6.1 6.7 6.3 8.9 8.5 13.4 12.1 10.4 12.0 13.2 11.9 13.1 10.9 12.9 13.8 12.2 11.9 254 302 323 286 279

5 10 15 20 90 180 270 360 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

移 植 人 數 ( 人 ) 移植率 移植數 移 植 率 ( 每 百 萬 人 口 )

(276)

2000~2015 Domestic Kidney Transplantation Rate

資料來源---健保資料庫,(xx): 年度目標數 註: 2016年數據乃推估而來,資料僅供參考。

(281) (287) (293) (299)

Transplant numbers Transplantation rate

2. Increase the numbers of renal transplantation (annual growth rate 3%) Not achieved: 2016, 2015: Numbers and rates fluctuated not constant Aim 2016, Tw RDS ADR

slide-25
SLIDE 25

Survival rate for chronic dialysis patients in Taiwan, 2000~2004

%

Chronic dialysis: undertaking dialysis for at least 3 months

ALL M F 0-19 20-39 40-64 65-74 75+

1y 2y 3y 5y 10y 5y survival rate 2000-2009 HD PD Tx All Aim 3. Improve dialysis 5-year survival rate (3% higher than EDTA Registry) 2016, Tw RDS ADR

slide-26
SLIDE 26

5-year survival rate, by age

Taiwan vs. Europe

26

Chronic dialysis: undertaking dialysis for at least 3 months

 2014 ESRD Annual Data Report

Eu Tw Eu Tw US

DM HT HD PD 2016, Tw RDS ADR

slide-27
SLIDE 27

5-year survival rate (International comparison)

USA EU TW TW

JP

Tw

3. Improve dialysis 5-year survival rate (3% higher than EDTA Registry) Achieved

Aim 2016, Tw RDS ADR

slide-28
SLIDE 28
  • No. and % of Incident PD patients of age <55 and Non-DM

28

285 391 361 401 377 414 538 532 492 499 523 442 410 444 426 409 443 15.1 19.6 21.8 24.8 34.8 33.4 33.7 34.9 30.8 30.4 31.8 30.1 31.0 0.0 10.0 20.0 30.0 40.0

200 400 600 800 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

人 數

人數 佔率

使 用 腹 膜 透 析 百 分 比 ( % )

註: 2016年數據乃推估而來,資料僅供參考。

Aim 4. Increase peritoneal dialysis penetration rate (annual growth rate 1% for age less than 55 years and non-diabetes group) All incident PD 2016, Tw RDS ADR

slide-29
SLIDE 29

29

18.3 19.0 18.0 18.0 17.8 18.0 18.5 19.9 20.4 20.8 21.4 21.5 21.1 21.0 21.0 20.8 20.9 10 20 30

1,000 2,000 3,000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

人 數

人數 佔率

佔 率 ( % )

  • No. and % of Prevalent PD patients of age <55 and

Non-DM

4. Increase peritoneal dialysis penetration rate (annual growth rate 1% for age less than 55 years and non-diabetes group) Not achieved,: 2016 vs. 2015:20.9%, vs. 20.8% ( +0.1%))(2015 vs. 2014: 20.8%, vs. 21.0% ( -0.2%)) Aim 2016, Tw RDS ADR

slide-30
SLIDE 30

What will be the new national goals for the next 5-year National Kidney Disease Prevention Project?

slide-31
SLIDE 31

Outlines

I.

Brief on the Taiwan CKD prevention works from 2003 to 2016

II.

The 5-year CKD Prevention and Quality of Care Improvement Project of Ministry of H & W, Taiwan

  • III. The New Cardiac-Kidney-Diabetes-Neuro Project
  • IV. Prospective
slide-32
SLIDE 32

CKD, a complex, multi-cause disease

1997-2008 Taiwan incident dialysis population

slide-33
SLIDE 33

Distribution of Taiwan patients with CKD, CHF, diabetes, & ESRD, 2004

Figure 12.26 USRDS 2007

Populations estimated from the 1 percent National Health Insurance (NHI) sample in Taiwan. Patients age 65 & older & all-age ESRD patients who survive the entire cohort year (2003), & period prevalent ESRD patients, 2004.

Distribution of costs for Taiwan patients with CKD, CHF, diabetes, & ESRD, 2004Figure 12.27

CKD, CHF, DM in elderly not only costive but also a multiplier for costs

slide-34
SLIDE 34

(<40Y/O)

*CAD *CVA *CVD

slide-35
SLIDE 35

A new concept for integrated care of CKD patients in new era

 The better care of renal function, the less

CV mortality, and longer survival time, but the higher chance of entering ESRD.

 Competing risk of death

ESRD

HT DM CKD

ESRD

CHF Pulmonary edema Coronary arterial Disease

Death Death

Renal palliative care RRT Tx, HD, PD

Polypharmacy, Multiple comorbidities, Ageing, Frequent hospitalization, High Costs, Poor QoL

slide-36
SLIDE 36

Percentage of incident dialysis patients under PreESRD care program before dialysis, by sex

2016, Tw RDS ADR

slide-37
SLIDE 37

腎臟病健康促進機構推展計畫 未來發展

CVD CKD DM

C-K-D

Through evaluation, education, dietary management, medical treatment, surgical intervention to reduce the mortality and complications.

Cardiol

  • gist

Nephr

  • logist

Diabetol

  • gist

A new care platform

A new C-K-D Cardiac-Kidney-Diabetes integrated care plan in new era

slide-38
SLIDE 38

健康訊息整合照護平台 Health information platform

衛教端 (nurse) 衛教師 個管師 醫師端 (Cardiac) 心臟內科 藥師端 (pharmacists) 營養師端 (nutritionists) 醫師端 (Kidney) 腎臟內科 醫師端 (Diabetes) 內分泌科

i-message

資料分析 Date analysis

醫師端 (Neuro) 神經內科

slide-39
SLIDE 39

2017~2021 2nd 5-year CKD Prevention and Quality

  • f Care Improvement Project : (Proposed by TSN)
  • Still under planning and

Discussion

  • The goals, strategy, KPI

achievement will be provided for government to make the national policy.

  • Needs collaborations

from different parties

  • Needs repeated

evaluation, modification, and improvement

 TSN consensus and suggestions  Generalized planning, from health

promotion to disease prevention, treatment, and QoL improvement

 Indicators  Health promotion and

prevention

 Reduce Sugar, Salt, and Oil use in

food manufacture  AKI prevention, CKD screening,

treatment, and management

 Based on Guidelines

 Age-standardized ESRD

incidence and prevalence

 Optimal goal to be reached

  • V. Perspective
slide-40
SLIDE 40

The secret of quality is love. You have to love your patient, you have to love your profession, you have to love your God. If you have love, you can then work backward to monitor and improve the system.

(Avedis Donabedian,1919~2000)

Wh What t is Qu Quality lity ?

slide-41
SLIDE 41

 Acknowledgement  Division of Nephrology, Dept. of Medicine  National Health Research Institute  Taiwan Society of Nephrology

Kaohsiung